UNIVERSITÄT LEIPZIG (@UniLeipzig) / Twitter
Universität Leipzig: Beschäftigte, Standort, Ehemalige | LinkedIn
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Kn
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Pharmaceutics & Novel Drug Delivery Systems
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards Therapy
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Mitarbeiter des Rudolf-Boehm-Institutes
MedChemComm
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Rudolf-Boehm-Institut für Pharmakologie und Toxikologie
